REGN vs TTEK · P/E 14, rev $14.34B vs P/E 17, rev $1.33B
Regeneron Pharmaceuticals Inc (REGN) versus Tetra Tech Inc (TTEK) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Tetra Tech Inc (TTEK) is a engineering & construction company listed on NASDAQ.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported TTEK revenue for 2025-09-28 was $1.33B. Net income was $247.9M. Revenue was down 2.9% from 2025-06-29 to 2025-09-28. TTEK currently screens at market cap $7.30B and trailing P/E 16.8.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. TTEK currently screens at market cap $7.30B and trailing P/E 16.8.
Not investment advice. Open the REGN and TTEK stock pages for the full models.
Not investment advice.